Lista de obras - Richard Haynes - Dominio Público Uruguay

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

artículo científico

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.

artículo científico publicado en 2017

Alemtuzumab induction therapy in kidney transplantation - Authors' reply

artículo científico publicado en 2015

Alemtuzumab: right drug, right dose?

scientific article published on 01 November 2011

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD

scientific article published on 12 December 2019

Aspirin for primary prevention of vascular disease in people with diabetes.

artículo científico publicado en 2009

Biliary Tract and Liver Complications in Polycystic Kidney Disease.

artículo científico publicado en 2017

CKD staging--evolution not revolution

artículo científico publicado en 2010

Chronic kidney disease: Does serum phosphate predict death and ESRD in CKD patients?

scientific article published on 02 July 2013

Chronic kidney disease: Statins in chronic kidney disease: time to move on?

artículo científico publicado en 2015

Commentary: Controversies in NICE guidance on chronic kidney disease

artículo científico publicado en 2008

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).

scientific article published on 13 June 2016

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).

artículo científico publicado en 2015

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men

article

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.

artículo científico publicado en 2018

Dual blockade of the renin-angiotensin system: are two better than one?

artículo científico publicado en 2009

Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio

artículo científico publicado en 2016

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

artículo científico publicado en 2017

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

artículo científico publicado en 2018

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease

artículo científico publicado en 2018

Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs

artículo científico

Effects of extended-release niacin with laropiprant in high-risk patients

artículo científico publicado en 2014

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial

artículo científico publicado en 2010

Effects of lowering LDL cholesterol on progression of kidney disease

artículo científico publicado en 2014

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus

artículo científico publicado en 2018

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)

artículo científico publicado en 2014

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease

artículo científico publicado en 2016

Evidence for the prevention and treatment of stroke in dialysis patients

artículo científico publicado en 2015

Feasibility of Telemonitoring Blood Pressure in Patients With Kidney Disease (Oxford Heart and Renal Protection Study-1): Observational Study

artículo científico publicado en 2018

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis

artículo científico publicado en 2018

Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency

artículo científico publicado en 2007

Homocysteine, the kidney, and vascular disease

scientific article published on 13 June 2012

How the NHS research governance procedures could be modified to greatly strengthen clinical research

artículo científico publicado en 2010

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study

artículo científico publicado en 2018

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.

artículo científico publicado en 2015

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

artículo científico publicado en 2016

Investigating modifications to participant information materials to improve recruitment into a large randomized trial

scientific article published on 05 December 2019

Kidney disease trials for the 21st century: innovations in design and conduct

scientific article published on 31 October 2019

Late presentation of patients with end-stage renal disease for renal replacement therapy--is it always avoidable?

artículo científico publicado en 2011

Neprilysin inhibition in chronic kidney disease

artículo científico publicado en 2015

Niacin: old habits die hard

artículo científico publicado en 2016

Outcomes of Elderly Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Treated with Immunosuppressive Therapy

artículo científico publicado en 2016

PCSK9 inhibition: ready for prime time in CKD?

artículo científico publicado en 2018

Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.

artículo científico publicado en 2009

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.

artículo científico publicado en 2018

Quiz page September 2013: a crystal clear diagnosis

artículo científico publicado en 2013

Reassuring results with regard to the effect of donor nephrectomy on cardiovascular outcomes

artículo científico publicado en 2009

Screening for risk with albuminuria: should we start from here?

artículo científico publicado en 2010

Serum free light chains and the risk of ESRD and death in CKD

artículo científico publicado en 2011

Simultaneous necrotizing glomerulonephritis and Hodgkin's lymphoma: a case report and review of the literature.

artículo científico publicado en 2011

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

artículo científico publicado en 2016

Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study.

artículo científico publicado en 2011

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.

artículo científico publicado en 2016

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection

artículo científico publicado en 2014

The role of lipoprotein (a) in chronic kidney disease

artículo científico publicado en 2018

Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP).

artículo científico publicado en 2016

Use of gel-based separator tubes to stabilise phosphate in mailed blood samples

article

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

artículo científico publicado en 2015

Lista de obras de Richard Haynes

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.

Alemtuzumab induction therapy in kidney transplantation - Authors' reply

Alemtuzumab: right drug, right dose?

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD

Aspirin for primary prevention of vascular disease in people with diabetes.

Biliary Tract and Liver Complications in Polycystic Kidney Disease.

CKD staging--evolution not revolution

Chronic kidney disease: Does serum phosphate predict death and ESRD in CKD patients?

Chronic kidney disease: Statins in chronic kidney disease: time to move on?

Commentary: Controversies in NICE guidance on chronic kidney disease

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).

Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older men

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.

Dual blockade of the renin-angiotensin system: are two better than one?

Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease

Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs

Effects of extended-release niacin with laropiprant in high-risk patients

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial

Effects of lowering LDL cholesterol on progression of kidney disease

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease

Evidence for the prevention and treatment of stroke in dialysis patients

Feasibility of Telemonitoring Blood Pressure in Patients With Kidney Disease (Oxford Heart and Renal Protection Study-1): Observational Study

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis

Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency

Homocysteine, the kidney, and vascular disease

How the NHS research governance procedures could be modified to greatly strengthen clinical research

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

Investigating modifications to participant information materials to improve recruitment into a large randomized trial

Kidney disease trials for the 21st century: innovations in design and conduct

Late presentation of patients with end-stage renal disease for renal replacement therapy--is it always avoidable?

Neprilysin inhibition in chronic kidney disease

Niacin: old habits die hard

Outcomes of Elderly Patients with Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Treated with Immunosuppressive Therapy

PCSK9 inhibition: ready for prime time in CKD?

Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.

Quiz page September 2013: a crystal clear diagnosis

Reassuring results with regard to the effect of donor nephrectomy on cardiovascular outcomes

Screening for risk with albuminuria: should we start from here?

Serum free light chains and the risk of ESRD and death in CKD

Simultaneous necrotizing glomerulonephritis and Hodgkin's lymphoma: a case report and review of the literature.

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Survival after starting renal replacement treatment in patients with autosomal dominant polycystic kidney disease: a single-centre 40-year study.

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection

The role of lipoprotein (a) in chronic kidney disease

Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP).

Use of gel-based separator tubes to stabilise phosphate in mailed blood samples

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?